Molecular structure of GEA 5583
GEA 5583
Application:
GEA 5583 is a stable NO releasing compound that is orally absorbed
Purity:
≥97%
Molecular Weight:
292.68
Molecular Formula:
C11H9ClN6O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
GEA 5583 is a stable nitric oxide releasing compound. Studies have shown that it is capable of altering protein expression in rat islets of Langerhans.
GEA 5583 References
- Cytokine- or chemically derived nitric oxide alters the expression of proteins detected by two-dimensional gel electrophoresis in neonatal rat islets of Langerhans. | John, NE., et al. 2000. Diabetes. 49: 1819-29. PMID: 11078448
- Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. | Nairz, M., et al. 2013. J Exp Med. 210: 855-73. PMID: 23630227
- Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. | Corell, T., et al. 1994. Pol J Pharmacol. 46: 553-66. PMID: 7542520
- Mesoionic oxatriazole derivatives--a new group of NO-donors. | Karup, G., et al. 1994. Pol J Pharmacol. 46: 541-52. PMID: 7620516
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GEA 5583, 10 mg | sc-205946 | 10 mg | $41.00 | |||
GEA 5583, 50 mg | sc-205946A | 50 mg | $164.00 |